The same study suggests that miR-379 increases cholesterol lipotoxicity, which promotes the development and progression of NAFLD by interfering with the expression of target genes, including those in the IGF-1 signaling pathway [59]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.